Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
Sponsor: Aalborg University
Summary
Atopic dermatitis (AD) is as chronic, inflammatory skin disorder affecting 20% of the world's population. Intense itch and skin pain are the main symptoms. Research has shown that the proteins interleukins are involved in inflammation and itch in atopic dermatitis. The medicinal product called Lebrikizumab, used for treatment of AD, has shown to block the interleukin called IL-13. The purpose of this experiment is to evaluate the role of IL-13 in itch in both healthy subjects and people with atopic dermatitis.
Official title: The Role of the Interleukin-13 Pathways on Pain and Itch Sensitivity in Patients With Atopic Dermatitis and Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-01-06
Completion Date
2026-12-31
Last Updated
2025-06-04
Healthy Volunteers
Yes
Conditions
Interventions
Histamine
A small drop of histamine dihydrochloride (1%, in saline) will be applied to a previously determined area on the volar forearm followed by a prick through the drop.
Cowhage
Approximately 30-35 cowhage spicules will be manually inserted into the subject's skin.
bovine adrenal medulla (BAM8-22)
A small drop of BAM8-22 solution will be applied to a previously determined area on the volar forearm followed by a prick through the drop.
Locations (3)
Aalborg University
Gistrup, Aalborg, Denmark
CNAP
Gistrup, Aalborg, Denmark
Aalborg University
Aalborg, Denmark, Denmark